(RF) properties have been inhomogeneous, consisting in part of the RF (4) (5) (6) .
This report concerns studies of SLE sera that precipitated at 0 to 40 C. In 12 SLE sera, the following were observed: 1) the association of cryoprecipitation with active disease manifestations, 2) inhomogeneity of cryoprecipitates consisting in part of 7 and 19 S y-globulin, and 3) the requirement for cryoprecipitation of a heatlabile (30 minutes at 560 C) component that could be supplied by normal human sera and the identification of the heat-labile substance as a recently characterized component of serum complement.
MATERIALS AND METHODS
Blood samples obtained from patients in the Edward Daniels Faulkner Arthritis Clinic and the Presbyterian
Hospital were allowed 'to clot in a 370 C water bath. Sera were separated from clotted blood by brief centrifugation at room temperature. The studies to be described were performed on fresh, unfrozen sera. See Table I for a summary of clinical and laboratory features of the 12 patients included in the present study.
2. Serum reagents for titration of complement components were prepared by previously reported methods (10) . The calorimetric method was standardized with a preparation of human -y-globulin whose nitrogen content was determined by Kjeldahl analysis.
4. The characterization of a heat-labile component required for cryoprecipitation was obtained by adding normal serum reagents to SLE sera heated at 560 C for 30 minutes. With all reagents other than the 11 S material and purified C',, the equivalent of 1 ml of treated normal serum was added to 1 ml of heated SLE sera, and the incubation and quantitation were carried out as described above.
5. Sedimentation studies of dissolved cryoprecipitates (0.15 M NaCl, 0.01 M phosphate buffer at pH 7.4) were performed in a model E Spinco analytical ultracentrifuge.
6. The technique of Grabar and Williams was utilized in immunoelectrophoretic studies (11) . Table II presents data obtained from a study of 10 SLE sera demonstrating significant cryoprecipitation. The values for precipitate nitrogen ranged between 12 and 63 )tg nitrogen per ml, t 500 U C', per ml.
RESULTS
t Heated* after addition of purified C',. (relatively deficient in C'3), ammonia-treated serum (relatively deficient in C'4), and the euglobulin fraction (relatively deficient in C2, C'3, and C'4) all reconstituted cryoprecipitation. Reagents lacking C'1 (heated normal human serum, immune precipitateabsorbed serum, and the supernatant fluid after removal of the euglobulin fraction) did not result in significant precipitation when added to heated SLE sera. Further evidence that C'1 might be the heat-labile factor required for cryoprecipitation derived from the effect of purified C'1 in reconstituting precipitation of heated SLE sera. More detailed studies of purified C'1 in which graded amounts of this reagent were added to two heated SLE sera are summarized in Table III . Although purified C'1 induced more precipitate than was obtained from untreated SLE serum in one subject (J.C.), a plateau effect was reached for both sera after addition of 0.25 to 0.5 ml purified C'1; larger amounts did not result in significant increases in precipitate formation. When heated serum of Subject R.J. was reheated after addition of purified C'1, the reconstituting property of the latter was lost.
Although the observations so far presented are compatible with the identification of the heat-labile component as C'1, the finding that disodium ethyl- normal serum factor required for reconstitution of cryoprecipitation of heated SLE sera: 1) heat lability, 2) coexistence with C'1 in standard complement reagents, and 3) normal or increased effect in the presence of EDTA (9, 15) . Table IV summarizes studies in which small amounts of 11 S material reconstituted cryoprecipitation of 4 heated SLE sera (Figure 1 illustrates a sedimentation pattern of the 11 S material used). When 2 sera (C.M. and E.T.) were reheated after addition of the 11 S material, increased precipitation did not occur. Other studies with 11 S material are presented in Table  V . Amounts of 11 S material varying between 9 and 180 ug nitrogen were added to samples of a heated SLE serum. A plateau effect was reached with 45 jig nitrogen; a further, fourfold increase in 11 S material did not increase cryoprecipitation. Forty-five ug 11 S material did not induce precipitation when added to normal human serum. When 11 S material was added to the supernatant fluid of untreated SLE serum after removal of cryoprecipitate, further precipitation was induced, indicating that for this serum, the 11 S material was the limiting reactant required for cryoprecipitation.
Analytical ultracentrifuge studies were performed on purified cryoproteins obtained from 8 SLE sera. In most cases, a small residue of precipitate was not soluble on warming to 370 C, so that materials in solution may not have reflected the total composition of cryoproteins. Sedimentation patterns of 3 cryoproteins are illustrated in Figure 2 . All of the cryoproteins examined demonstrated predominantly 7 S material with varying quantities of more rapidly sedimenting components.
Purified cryoproteins from 4 SLE sera were studied by immunoelectrophoresis with horse antihuman antiserum. Two antigens, Y2-and ylm-globulins, were consistently demonstrable (see Figure 3) . DISCUSSION Occasional reference has been made to the association of SLE and cryoproteinemia. Coburn and Moore, in an electrophoretic study of certain SLE sera, noted a dense precipitation in the part of the Tiselius tube containing globulin (16). Barr, Reader, and Wheeler found significant cryoproteinemia in 8 of 121 random human sera (17) . Three of these 8 were SLE sera (total of 6 SLE 827 sera included in the 121 studied). Waldenstrdm referred to a §ingle case of SLE that exhibited cryoproteinemia ( 18) ,.
The magnitude of cryoprecipitation reported here (7 to 38 mg per 100 ml) is equivalent to grade 2 cryoglobulinemia in Lerner's studies.
Cryoproteinemia of this degree is rarely encountered. Our group of patients is not a random sampling of SLE patients. Screening tests were applied to virtually all hospitalized patients, although the outpatient population was incompletely surveyed. All patients with cryoproteinemia, however, showed signs of active SLE. During the 3 years of study, 18 of 33 sera examined contained at least 10 jug nitrogen per ml serum. Of these patients, 8 are known to have died; significant renal -disease was present in 15; only 5 patients had Raynaud's symptoms.
The requirement of a component of complement (11 S material) for cryoprecipitation may be significantly related to the nature of the reactants participating in precipitate formation and to the pathogenesis of SLE. Heat-labile cryoprecipitation in another report concerned a patient with "essential cryoglobulinemia" (19) .
Current knowledge suggests that the 11 S component of complement reacts with immune complexes or with aggregates of y-globulin. [yGlobulin aggregates share other properties with immune complexes: reactivity with rheumatoid factor (20, 21) and the capacity to induce cutaneous inflammatory lesions (22, 23) .] The precipitation of otherwise soluble components of SLE sera by 11 S material is apparently analogous to the action of complement in rendering soluble immune complexes insoluble (24) (25) (26) . The presumed aggregates in SLE sera that are reactive with 11 S material might be either the products of nonspecific aggregation of y-globulin, or, conceivably, immune complexes. The evidence of this report does not clearly support one of the above possibilities to the exclusion of the other. The -y-globulin constituents of dissolved cryoproteins could represent antibodies dissociated from immune complexes, but the antigen of the hypothetical immune complex was not demonstrable. One could postulate that the immune complexes might be anti-y-globulin antibodies in combination with autologous y-globulin. Such a basis has been suggested for the intermediate complexes of yglobulin observed in certain rheumatoid sera (27) .
Evidence of in vivo fixation of complement in SLE derives from demonstrations of low total serum complement (28) (29) (30) . A study of components of complement revealed depressions of the 11 S material as well as decreases in other components in SLE sera (31) . Immunoelectrophoretic studies of SLE sera demonstrated marked reduction of a globulin, B1-globulin, subsequently shown to be a component of complement (32, 33) . Immunofluorescent studies demonstrated the presence of B1-globulin in renal lesions of SLE (34 
